据美国公益科学中心(CSPI)网站消息,6月25日美国公益科学中心要求FDA对能量饮料相关的心脏病、痉挛等不良反应实施标签警示。
美国公益科学中心称,自2012年底以来,17起未报告的死亡病例被认为跟咖啡因饮料,也就是能量饮料有关联。
作为进一步的预防措施,该组织还要求制造商将能量饮料中的咖啡因含量降至0.02%或每12盎司71毫克,同时要求对能量饮料中使用的各种化学和草药成分的安全效应及与咖啡因可能的相互作用进一步研究。
部分原文报道如下:
CSPI today asked FDA commissioner Margaret Hamburg to require warning labels on energy drink containers notifying consumers of the risk of heart attack, convulsion, and other adverse reaction to energy drinks. As a further precaution, the group asked the agency to require manufacturers to lower caffeine levels in the drinks to 0.02 percent, or 71 milligrams per 12 ounces-the maximum amount the FDA considers safe in cola-style beverages. Also, CSPI asked the agency to require careful studies on the health effects of the various chemical and herbal ingredients (such as taurine, glucuronolactone, carnitine, ginseng, ginkgo biloba, milk thistle extract, and guarana seed) used in energy drinks and their possible interactions with caffeine.
原文链接:<https://www.cspinet.org/new/201406251.html>